Inhibition of Erythrocyte Cation Channels by Erythropoietin

Journal of the American Society of Nephrology

Volumn 14, Issue 11, 2003, Pages 2750-2757

  Myssina, Svetlana ^a   Huber, Stephan M ^a   Birka, Christina ^a   Lang, Philipp A ^a   Lang, Karl S ^a   Friedrich, Björn ^b   Risler, Teut ^b   Wieder, Thomas ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 (N ETHYL N ISOPROPYL)AMILORIDE; ANNEXIN; CALCIUM; CATION CHANNEL; CHLORIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IODINE 125; PHOSPHATIDYLSERINE; RECOMBINANT ERYTHROPOIETIN; SCRAMBLASE;

ANEMIA; APOPTOSIS; ARTICLE; ASYMMETRIC CATALYSIS; CALCIUM TRANSPORT; CELL MEMBRANE; CELL SURVIVAL; CHLORIDE TRANSPORT; CONTROLLED STUDY; DIALYSIS; ERYTHROCYTE; ERYTHROCYTE COUNT; HEMODIALYSIS; HUMAN; HUMAN CELL; HYPEROSMOLARITY; KIDNEY FAILURE; OSMOTIC STRESS; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN BINDING; STEM CELL;

EID: 0142213938     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000093253.42641.C1     Document Type: Article

References (55)

1. Jelkmann W: Erythropoietin: Structure, control of production, and function. Physiol Rev 72: 449-489, 1992
2. Digicaylioglu M, Lipton SA: Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412: 641-647, 2001
3. Grimm C, Wenzel A, Groszer M, Mayser H, Seeliger M, Samardzija M, Bauer C, Gassmann M, Reme CE: HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 8: 718-724, 2002
4. Kaupke CJ, Kim S, Vaziri ND: Effect of erythrocyte mass on arterial blood pressure in dialysis patients receiving maintenance erythropoietin therapy. J Am Soc Nephrol 4: 1874-1878, 1994
5. Coladonato JA, Frankenfield DL, Reddan DN, Klassen PS, Szczech LA, Johnson CA, Owen WF Jr: Trends in anemia management among US hemodialysis patients. J Am Soc Nephrol 13: 1288-1295, 2002
6. Eschbach JW: Anemia management in chronic kidney disease: Role of factors affecting epoetin responsiveness. J Am Soc Nephrol 13: 1412-1414, 2002
7. Polenakovic M, Sikole A: Is erythropoietin a survival factor for red blood cells? J Am Soc Nephrol 7: 1178-1182, 1996
8. Koury MJ, Bondurant MC: Erythropoietin retards DNA break-down and prevents programmed death in erythroid progenitor cells. Science 248: 378-381, 1990
9. Adamson JW: The relationship of erythropoietin and iron metabolism to red blood cell production in humans. Semin Oncol 21: 9-15, 1994
10. Kimura T, Sonoda Y, Iwai N, Satoh M, Yamaguchi-Tsukio M, Izui T, Suda M, Sasaki K, Nakano T: Proliferation and cell death of embryonic primitive erythrocytes. Exp Hematol 28: 635-641, 2000
11. Orkin SH, Weiss MJ: Apoptosis: Cutting red-cell production. Nature 401: 433, 435-436, 1999
12. Daugas E, Cande C, Kroemer G: Erythrocytes: Death of a mummy. Cell Death Differ 8: 1131-1133, 2001
13. Berg CP, Engels IH, Rothbart A, Lauber K, Renz A, Schlosser SF, Schulze-Osthoff K, Wesselborg S: Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis. Cell Death Differ 8: 1197-1206, 2001
14. Bratosin D, Estaquier J, Petit F, Arnoult D, Quatannens B, Tissier JP, Slomianny C, Sartiaux C, Alonso C, Huart JJ, Montreuil J, Ameisen JC: Programmed cell death in mature erythrocytes: A model for investigating death effector pathways operating in the absence of mitochondria. Cell Death Differ 8: 1143-1156, 2001
15. Zhou Q, Zhao J, Wiedmer T, Sims PJ: Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1. Blood 99: 4030-4038, 2002
16. Lang KS, Roll B, Myssina S, Schittenhelm M, Scheel-Walter HG, Kanz L, Fritz J, Lang F, Huber SM, Wieder T: Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase deficiency. Cell Physiol Biochem 12: 365-372, 2002
17. Lang KS, Duranton C, Poehlmann H, Myssina S, Bauer C, Lang F, Wieder T, Huber SM: Cation channels trigger apoptotic death of erythrocytes. Cell Death Differ 10: 249-256, 2003
18. Lang KS, Myssina S, Tanneur V, Wieder T, Huber SM, Lang F, Duranton C: Inhibition of erythrocyte cation channels and apoptosis by ethylisopropylamiloride. Naunyn Schmiedebergs Arch Pharmacol 367: 391-396, 2003
19. Boas FE, Forman L, Beutler E: Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. Proc Natl Acad Sci U S A 95: 3077-3081, 1998
20. Eda S, Sherman IW: Cytoadherence of malaria-infected red blood cells involves exposure of phosphatidylserine. Cell Physiol Biochem 12: 373-384, 2002
21. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM: A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405: 85-90, 2000
22. 2+ influx into human red cells. Cell Calcium 26: 131-137, 1999
23. Kiefer CR, Snyder LM: Oxidation and erythrocyte senescence. Curr Opin Hematol 7: 113-116, 2000
24. Damonte G, Guida L, Sdraffa A, Benatti U, Melloni E, Forteleoni G, Meloni T, Carafoli E, De Flora A: Mechanisms of perturbation of erythrocyte calcium homeostasis in favism. Cell Calcium 13: 649-658, 1992
25. Ruymann FB, Popejoy LA, Brouillard RB: Splenic sequestration and ineffective erythropoiesis in hemoglobin E-beta-thalassemia disease. Pediatr Res 12: 1020-1023, 1978
26. Corash L, Spielberg S, Bartsocas C, Boxer L, Steinherz R, Sheetz M, Egan M, Schlessleman J, Schulman JD: Reduced chronic hemolysis during high-dose vitamin E administration in Mediterranean-type glucose-6-phosphate dehydrogehase deficiency. N Engl J Med 303: 416-420, 1980
27. Benjamin LJ, Manning JM: Enhanced survival of sickle erythrocytes upon treatment with glyceraldehyde. Blood 67: 544-546, 1986
28. Yang XY, Qu Q, Yang TY, Chan WC, Chu JX, Chen Z, Ning AL, Liu FJ, Lin ZX, Zhou YL: Treatment of the thalassemia syndrome with splenectomy. Hemoglobin 12: 601-608, 1988
29. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ: Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391: 85-100, 1981
30. Huber SM, Gamper N, Lang F: Chloride conductance and volume-regulatory nonselective cation conductance in human red blood cell ghosts. Pflugers Arch 441: 551-558, 2001
31. Barry PH, Lynch JW: Liquid junction potentials and small cell effects in patch-clamp analysis. J Membr Biol 121: 101-117, 1991
32. Andree HA, Reutelingsperger CP, Hauptmann R, Hemker HC, Hermens WT, Willems GM: Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem 265: 4923-4928, 1990
33. Spivak JL, Avedissian LS, Pierce JH, Williams D, Hankins WD, Jensen RA: Isolation of the full-length murine erythropoietin receptor using a baculovirus expression system. Blood 87: 926-937, 1996
34. Wieder T, Perlitz C, Wieprecht M, Huang RT, Geilen CC, Orfanos CE: Two new sphingomyelin analogues inhibit phosphatidylcholine biosynthesis by decreasing membrane-bound CTP: Phosphocholine cytidylyltransferase levels in HaCaT cells. Biochem J 311 (Pt 3). 873-879, 1995
35. Duranton C, Huber SM, Lang F: Oxidation induces a Cl(-)dependent cation conductance in human red blood cells. J Physiol 539: 847-855,2002
36. Sawada K, Krantz SB, Dai CH, Koury ST, Horn ST, Glick AD, Civin CI: Purification of human blood burst-forming units: Erythroid and demonstration of the evolution of erythropoietin receptors. J Cell Physiol 142: 219-230, 1990
37. Broudy VC, Lin N, Brice M, Nakamoto B, Papayannopoulou T: Erythropoietin receptor characteristics on primary human erythroid cells. Blood 77: 2583-2590, 1991
38. Bonomini M, Sirolli V, Settefrati N, Dottori S, Di Liberato L, Arduini A: Increased erythrocyte phosphatidylserine exposure in chronic renal failure. J Am Soc Nephrol 10: 1982-1990, 1999
39. Rosette C, Karin M: Ultraviolet light and osmotic stress: Activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 274: 1194-1197, 1996
40. Roger F, Martin PY, Rousselot M, Favre H, Feraille E: Cell shrinkage triggers the activation of mitogen-activated protein kinases by hypertonicity in the rat kidney medullary thick ascending limb of the Henle's loop: Requirement of p38 kinase for the regulatory volume increase response. J Biol Chem 274: 34103-34110, 1999
41. Maeno E, Ishizaki Y, Kanaseki T, Hazama A, Okada Y: Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. Proc Natl Acad Sci U S A 97: 9487-9492, 2000
42. Michea L, Ferguson DR, Peters EM, Andrews PM, Kirby MR, Burg MB: Cell cycle delay and apoptosis are induced by high salt and urea in renal medullary cells. Am J Physiol Renal Physiol 278: F209-F218, 2000
43. Gulbins E, Jekle A, Ferlinz K, Grassme H, Lang F: Physiology of apoptosis. Am J Physiol Renal Physiol 279: F605-F615, 2000
44. Volk T, Fromter E, Korbmacher C: Hypertonicity activates nonselective cation channels in mouse cortical collecting duct cells. Proc Natl Acad Sci U S A 92: 8478-8482, 1995
45. + conductance of rat hepatocytes in primary culture. J Gen Physiol 105: 507-535., 1995
46. Wehner F, Bohmer C, Heinzinger H, van den Boom F, Tinel H: The hypertonicity-induced Na(+) conductance of rat hepatocytes: Physiological significance and molecular correlate. Cell Physiol Biochem 10: 335-340,2000
47. Cabado AG, Vieytes MR, Botana LM: Effect of ion composition on the changes in membrane potential induced with several stimuli in rat mast cells. J Cell Physiol 158: 309-316, 1994
48. Chan HC, Goldstein i, Nelson DJ: Alternate pathways for chloride conductance activation in normal and cystic fibrosis airway epithelial cells. Am J Physiol 262: C1273-C1283, 1992
49. Gamper N, Huber SM, Badawi K, Lang F: Cell volume-sensitive sodium channels upregulated by glucocorticoids in U937 macrophages. Pflugers Arch 441: 281-286, 2000
50. Koch J, Korbmacher C: Osmotic shrinkage activates nonselective cation (NSC) channels in various cell types. J Membr Biol 168: 131-139, 1999
51. Pinton P, Ferrari D, Rapizzi E, Di Virgilio F, Pozzan T, Rizzuto R: A role for calcium in Bcl-2 action? Biochimie 84: 195-201, 2002
52. Elliott JI, Higgins CF: IKCal activity is required for cell shrinkage, phosphatidylserine translocation and death in T lymphocyte apoptosis. EMBO Rep 4: 189, 194, 2003
53. Bao H, Jacobs-Helber SM, Lawson AE, Penta K, Wickrema A, Sawyer ST: Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells). Blood 93: 3757-3773, 1.999
54. Haseyama Y, Sawada K, Oda A, Koizumi K, Takano H, Tarumi T, Nishio M, Handa M, Ikeda Y, Koike T: Phosphatidylinositol 3-kinase is involved in the protection of primary cultured human erythroid precursor cells from apoptosis. Blood 94: 1568-1577,1999
55. Brines M: What evidence supports use of erythropoietin as a novel neurotherapeutic? Oncology (Huntingt) 16: 79-89, 2002